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MeCP2 is a transcriptional regulator important for neurodevelopment and is involved in Rett syndrome and
autism. In this issue of Developmental Cell, Cheng and colleagues (2014) report that MeCP2 also regulates
microRNA biogenesis. MeCP2 phosphorylation induces a direct interaction with DGCR8, leading to reduced
microRNA processing and retardation of dendritic growth.MicroRNAs (miRNAs) have emerged as
key modulators of gene expression in
virtually all biological processes including
cell proliferation, survival, and differentia-
tion (Bronevetsky and Ansel, 2013; Kim
et al., 2009). miRNA formation begins
with RNA polymerase II-mediated tran-
scription, which yields long primary
transcripts (pri-miRNAs) harboring a local
hairpin structure (Figure 1). The hairpin
is cleaved by the nuclear RNase III Drosha
to release a miRNA precursor (pre-
miRNA) 60 nucleotides (nt) in length.
This pre-miRNA is then exported to the
cytoplasm and processed by Dicer to
produce an 22 nt RNA duplex, which is
then loaded onto Argonaute (Ago). One
strand of the duplex is removed, while
the other strand remains in Ago as mature
miRNA that directs gene silencing by
base pairing with the target mRNAs.
Because Drosha processing is a key
step in determining miRNA abundance,
multiple mechanisms are employed to
control the level, activity, and specificity
of Drosha. DiGeorge syndrome critical
region gene 8 (DGCR8) is an essential
cofactor for Drosha. DGCR8 provides an
RNA binding platform for pri-miRNAs
and interacts with Drosha to form a
complex called Microprocessor. The level
of Microprocessor is maintained through
crossregulation between Drosha and
DGCR8. Drosha destabilizes DGCR8
mRNA by cleaving a hairpin structure
embedded within DGCR8. In turn,
DGCR8 stabilizes Drosha protein via a
protein-protein interaction. This deeply
conserved regulatory loop contributes
to the homeostatic control of Micropro-
cessor. The RNA-binding protein TDP-43
may also interact with and increase thestability of Drosha protein. This activity
of TDP-43 may be significant in the con-
text of neuronal differentiation. In addi-
tion, the intracellular stability, nuclear
localization, and processing activity of
Microprocessor can be regulated by
posttranslational modification such as
phosphorylation and acetylation. Drosha
processing is often controlled specifically
for a subset of miRNAs. The specificity
of regulation is dictated by RNA binding
proteins that interact selectively with
certain pri-miRNAs. For instance, Lin28
and KH-type splicing regulatory factor
(KSRP) interact with the terminal loop
of pri-let-7 to inhibit and enhance let-7
biogenesis, respectively. Dead-box RNA
helicases p68 (also known as DDX5) and
p72 (also known as DDX17) are also
known to be required for a subset of
miRNAs, although the mechanism under-
lying their specificity remains unclear.
The SMAD proteins, ERa, and p53 regu-
late Microprocessor activity through
their interaction with the aforementioned
helicases.
In this issue of Developmental Cell,
Cheng and colleagues (2014) introduce
yet another type of miRNA processing
regulator. Methyl-CpG binding protein 2
(MeCP2) is a transcriptional repressor
with the ability to bind to methylated
CpG islands and recruit a histone deace-
tylase complex (Damen and Heumann,
2013; Nan et al., 1997). In addition to
this function, it has been reported to
participate in processes such as tran-
scriptional activation, chromatin remodel-
ing, and RNA splicing. It is ubiquitously
expressed throughout the mammalian
body, with higher expression levels seen
in the central nervous system (CNS).Developmental Cell 2MeCP2 levels need to be tightly controlled
for normal development and function
of the CNS. Loss-of-function mutations
in the human MECP2 gene cause Rett
syndrome (RTT), an X-linked neurologic
disorder, while duplication of theMECP2-
containing loci is associated with autism
spectrum disorders (Damen and Heu-
mann, 2013). In a mouse model of Rett
syndrome with mecp2 deletion, miRNA
expression profile is altered, implicating
a potential link between MeCP2 and the
miRNA pathway (Szulwach et al., 2010;
Urdinguio et al., 2010; Wu et al., 2010).
In the current study, Cheng et al. (2014)
examined the abundance of miRNA
processing intermediates in MeCP2-
depleted cells. Intriguingly, the pri-miRNA
levels did not change, whereas the
pre-miRNA and mature miRNA levels
increased, suggesting that MeCP2 may
act at the posttranscriptional level.
Indeed, the C-terminal domain of MeCP2
(but not its methyl-DNA binding domain)
was found to directly interact with the
two RNA-binding domains of DGCR8.
The C-terminal deletion MeCP2 mutant
is as active as the wild-type in its repres-
sion of transcription targets, and yet the
C-terminal mutations account for 15%
of all genetic mutations in the Rett syn-
drome patients. This suggests that the
C terminus of MeCP2 has a function inde-
pendent of the transcriptional activity. The
authors further expanded on the finding
that MeCP2 binds to DGCR8 by showing
that MeCP2 competes with Drosha and
promotes the release of Drosha from
DGCR8, thus inactivating Microprocessor
(Figure 1).
MeCP2 phosphorylation is dynamically
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Figure 1. Model for the Regulation of Pri-miRNA Processing by MeCP2
Ser80 of MeCP2 is dephosphorylated upon neural depolarization. Dephosphorylated MeCP2 adopts a
closed conformation and cannot bind to DGCR8 (left), allowing pri-miRNAs to be efficiently processed
by the Drosha-DGCR8 (Microprocessor) complex. This produces mature miRNAs that in turn suppress in-
hibitors of dendritic growth. In the absence of calcium signaling, MeCP2 is phosphorylated and adopts an
open conformation that allows it to bind DGCR8 and release Drosha (right). Under this condition, miRNA
biogenesis is blocked, resulting in reduced dendritic growth.
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Previewswith rapid dephosphorylation of Ser80
seen following neuronal activity, and
this modification was previously shown
to affect the chromatin association
and subsequent gene regulation by
MeCP2 (Damen and Heumann, 2013).
Cheng et al. (2014) found that a phosphor-
ylation-deficient MeCP2 mutant (Ser80 to
alanine) has a lower affinity for DGCR8,
while the phosphomimetic mutant (Ser80
to aspartate) binds DGCR8more strongly.
In cultured cortical neurons, KCl-induced
depolarization resulted in a dissociation
of DGCR8 from MeCP2. Fluorescence
resonance energy transfer (FRET) experi-
ments using MeCP2 fused to CFP and
YFP at the N and C termini, respectively,
suggested that phosphorylation of Ser80
induces a conformational change into an
open state, which allows MeCP2 to bind
DGCR8 (Figure 1). The FRET signal
increased in neurons following a depolari-
zation stimulus, indicating a closed and
inactive conformation upon neuronal ac-
tivity, which may then derepress miRNA
processing. The upstream phosphatase
responsible for this regulation is yet to be
uncovered.
To further understand the biological
significance of MeCP2 phosphorylation478 Developmental Cell 28, March 10, 2014 ªand DGCR8 interaction in neural devel-
opment, Cheng et al. (2014) went on
to examine the miRNAs regulated by
this interaction, focusing on miR-134,
which targets three important regulators
of neural development and plasticity:
CREB, LIMK1, and Pumilio2. The levels
of these targets decreased in mecp2
knockout mice, whereas they were
elevated in mecp2 transgenic mice. The
miRNA-134 target levels increased and
dendritic growth was inhibited when the
wild-type MeCP2 (but not the phospho-
deficient mutant) was overexpressed in
cultured neurons, which is similar to the
phenotype seen in MECP2 duplication
disorders. Notably, this inhibition was
rescued by introducing miR-134, indi-
cating that MeCP2 exerts its effects,
at least partly, by repressing miR-134
processing.
This study uncovers a novel type of
regulator that directly targets a micropro-
cessor component, raising the possibility
that there may be additional proteins
that function in a similar manner in
other tissues and at other developmental
stages. This study also leaves many
questions unanswered. The proposed
model suggests that the impact of2014 Elsevier Inc.MeCP2 should go beyond miR-134 and
its targets in neurons, because MeCP2
affects miRNA levels globally. It remains
unclear to what extent other miRNAs
(apart from miR-134) contribute to the
observed neural phenotype. Moreover,
because MeCP2 is expressed ubiqui-
tously, it will be intriguing to know
whether MeCP2 serves as a nega-
tive regulator of the miRNA pathway in
nonneuronal tissues. Additionally, how
neuronal activity affects MeCP2 in this
context is not fully understood. Specif-
ically, which phosphatase dephosphory-
lates MeCP2, and how does calcium
signaling trigger MeCP2 dephosphoryla-
tion? Lastly, how much of the biological
function of MeCP2 can be attributed
to its interaction with DGCR8, and is
there a mechanistic link between the
seemingly independent miRNA sup-
pression, transcriptional regulation, and
splicing control activities of MeCP2?
Caught moonlighting, MeCP2 is now fac-
ing a multifaceted investigation.REFERENCES
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